Nuclear survivin staining intensities did not significantly correlate with biochemical recurrence (p = 0.16, Fig. 4B), onset of metastatic disease (p = 0.18), or cancer-related survival (p = 0.05). This evidence concerns the gene BIRC5 and metastatic neoplasm.